Carpal tunnel syndrome is a painful condition caused by a compressed nerve in the hand. It causes pain, numbness, tingling, and a variety of other symptoms, and affects roughly 3% of the world population. Luckily, thanks to its anti-inflammatory and pain-relieving properties, cannabis may offer an attractive treatment option to patients with carpal tunnel syndrome.


Given that the main symptoms of carpal tunnel syndrome are pain and inflammation, cannabis is an attractive option. And while regular medications like NSAIDs and steroids can offer effective relief from carpal tunnel symptoms, their misuse or continued use can cause side effects.

NSAIDs, for example, can cause gastrointestinal bleeding, heartburn, headaches, dizziness, liver and kidney problems, high blood pressure, and much more. Studies show that in the US, around 100,000 people are hospitalised every year from gastrointestinal issues related to NSAIDs alone. It makes looking for alternatives attractive.

Over the last decade, a number studies have shown that various constituents of cannabis have anti-inflammatory and pain-relieving effects. In 2013, for example, researchers from the Tongji University School of Medicine found that CBD may significantly decrease inflammation[1] in an animal-based study of pancreatitis.

In 2012, a study published in the _European Journal of Pharmacology_ suggested that CBD may decrease inflammation[2] in rats with acute lung injury. In 2011, researchers from the University of Naples Federico II found CBD also seemed to reduce chronic inflammation[3] in the gut. Other studies show how CBD could help reduce inflammation caused by arthritis[4] and IBS[5].

This being said, much more research is needed, so it is not yet clear how effectively cannabis can help with carpal tunnel syndrome. Research specifically targeting the condition and its relation to cannabis needs to be conducted. However, current research into the area is promising, if not definite yet.

External Resources:
  1. Anti-inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice - PubMed
  2. Cannabidiol, a Non-Psychotropic Plant-Derived Cannabinoid, Decreases Inflammation in a Murine Model of Acute Lung Injury: Role for the Adenosine A(2A) Receptor - PubMed
  3. Cannabidiol Reduces Intestinal Inflammation Through the Control of Neuroimmune Axis - PubMed
  4. Preliminary Assessment of the Efficacy, Tolerability and Safety of a Cannabis-Based Medicine (Sativex) in the Treatment of Pain Caused by Rheumatoid Arthritis - PubMed
  5. Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview - PubMed
This content is for educational purposes only. The information provided is derived from research gathered from external sources.

Are you aged 18 or over?

The content on is only suitable for adults and is reserved for those of legal age.

Ensure you are aware of the laws of your country.

By clicking ENTER, you confirm
you are
18 years or older